UPDATE 1-Inhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study

(Updates shares in bullet 6, adds analyst comment in bullet 4) By Sneha S K Sept 8 (Reuters) – Inhibrx Biosciences said on Tuesday its experimental combination cancer drug helped reduce tumors in a

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)